SCHEMBL14545261

SCHEMBL14545261

Bc1cnn2c(NCCNC(=O)c3cccnc3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 5/20 0.53
▸ GSK3B P49841 4/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ EPHX2 P34913 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13288743 0.90 CDK2 (0.67) CDK2GSK3B
SCHEMBL14545970 0.87 GSK3B (0.45) CDK2GSK3BCYP2C19
SCHEMBL13288868 0.87 CDK2 (0.52) CDK2GSK3BCYP2C9CYP2C19
SCHEMBL13288754 0.87 CDK2 (0.45) CDK2GSK3BSMN1; SMN2KMT2ALMNA
SCHEMBL14545832 0.86 CDK2 (0.48) CDK2GSK3BSMN1; SMN2LMNANPC1
SCHEMBL14613373 0.86 EPHX2 (0.44) CDK2GSK3BSMN1; SMN2KMT2ANPC1
SCHEMBL13288854 0.86 GSK3B (0.48) CDK2GSK3BSMN1; SMN2KMT2AMEN1
SCHEMBL13288899 0.84 GSK3B (0.43) CDK2GSK3BSMN1; SMN2KMT2ANPC1
SCHEMBL13120200 0.84 CDK2 (0.65) CDK2GSK3BPOLB
SCHEMBL13288895 0.84 GSK3B (0.43) CDK2GSK3BSMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback